Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

Combination Therapy Appears Helpful For Short-Term Treatment Of Insomnia; Cognitive Behavior Therapy May Be Better For Long-Term
For patients with persistent insomnia, a combination of cognitive behavior therapy (CBT) and the medication zolpidem for 6 weeks was associated with improvement in sleep, although for a longer treatment period CBT alone was more beneficial, according to a study in the May 20 issue of JAMA. Don't forget to buy zoloft online no prescription.

South African Health Minister To Launch PMTCT Plan
South African Health Minister Aaron Motsoaledi within the next two weeks is expected to launch a plan to address mother-to-child HIV transmission in an effort to reduce infant mortality in the country, The Times reports. The MTCT plan is part of a new health program adopted by President Jacob Zuma"s administration, according to The Times."This is one of the most urgent things I want to (deal with) as the new minister," Motsoaledi said. According to Motsoaledi, a child dies every eight minutes in South Africa, and about 40% of child deaths are related to HIV/AIDS. The plan was developed by the Development Bank of Southern Africa at a July meeting of government and health sector stakeholders. Participants at the meeting also examined maternal deaths and the decrease in life expectancy among young adults because of HIV/AIDS. According to Motsoaledi, these and other issues have been identified as priorities for the Zuma administration if South Africa is to meet targets in the United Nations Millennium Development Goals. They also have been consolidated into a 10-point plan to help the Department of Health focus on urgent issues through 2015."Health and education are the biggest challenges for (the government) and we ought to be doing something drastic," Motsoaledi said, adding, "These are very serious issues in society." The health department"s plan also calls for the revival of the National AIDS Council and says that the government should improve regulation of the private health sector. It also calls for the establishment of a national tuberculosis reference laboratory, a focus on infection rates among women ages 17 to 21 and the improvement of HIV prevention among commercial sex workers (Molele, The Times, 5/25).

generic viagra online


News of the day
New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals To Access Electronic Medical Records (EMR) Directly At The Point Of Care
InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced the introduction of a new mobility offering for healthcare providers, the InfoLogix M24 mobile clinical assistant: a powerful mobile computing solution that enables medical professionals to access critical patient information at the point-of-care.
Medical Devices

BIO Comments On White House Letter On Biosimilars

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the letter sent yesterday from the Obama Administration to House Energy and Commerce Committee Chairman Henry Waxman regarding biosimilars: "The Biotechnology Industry Organization continues to support strongly the development of a pathway for the review and approval of biosimilars. "We are extremely concerned that the seven years of data exclusivity called for by the administration in the letter points to a risky short cut to biosimilars. We believe this abbreviated period will undermine the incentives necessary for continued biotech research into breakthrough medicines and cures for diseases such as cancer, multiple sclerosis, Alzheimer"s and HIV/AIDS as well as unmet medical needs. "As we have consistently said, any pathway to biosimilars should provide a fair period of time for innovators to protect their proprietary data from competitors in order to promote the continued development of breakthrough medicines, therapies and cures. We continue to believe that fourteen years of data exclusivity will strike the appropriate, reasonable and fair balance between our common desire to expand access to breakthrough biotech medicines and the need to preserve the protections necessary to promote further biomedical advances. In addition, it will provide biologics manufacturers with the same effective protections provided to small molecule drug manufacturers. This is the approach supported by the 110 bipartisan cosponsors of H.R. 1548, the Pathway for Biosimilars Act, along with more than 105 patient advocacy, physician, academic and innovator groups who join us in supporting H.R. 1548. "We are disappointed the administration chose to base its policy upon the Federal Trade Commission (FTC) report. This report was based upon highly selective assumptions and has been rejected by many members of Congress as fundamentally flawed. Following the recommendations in the report will place at risk the more than 7.5 million high wage, high-quality American jobs supported by the biotech industry and jeopardize our nation"s global competitive advantage in biomedical innovation. "We look forward to continuing to work with the Obama administration and the Congress to develop a bipartisan pathway to biosimilars that places patient safety at its center, reduces costs, expands access and promotes continued biomedical advances for patients." BIO


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009